Yataco, M , Cowell, A , Waseem, D , Keaveny, AP , Taner, CB , Patel, T

Language: English
References: 16
Page: 356-362
PDF size: 148.28 Kb.

ABSTRACT

While liver transplantation is the definitive therapy for end stage liver disease, it remains a major procedure, with many potential complications. Hospital readmissions after the initial hospitalization for liver transplantation can be associated with adverse outcomes, increased cost, and resource utilization. Our aim was to define the incidence and reasons for hospital readmission after liver transplant and the impact of readmissions on patient outcomes. We retrospectively analyzed 30- and 90-day readmission rates and indications in patients who underwent liver transplant at a large-volume transplant center over a 3-year period. Four hundred seventy-nine adult patients underwent their first liver transplant during the study period. The 30-day readmission rate was 29.6%. Recipient and donor age, etiology of liver disease, biological Model for End-Stage Liver Disease score, and cold ischemia time were similar between patients who were readmitted within 30 days and those who were not readmitted. Readmissions occurred in 25% of patients who were hospitalized prior to liver transplant compared to 30% who were admitted for liver transplant. The most common indications for readmission were infection, severe abdominal pain, and biliary complications. Early discharge from hospital (fewer than 7 days after liver transplant), was not associated with readmission; however, a prolonged hospital stay after liver transplant was associated with an increased risk of readmission (p = 0.04). In conclusion, patients who undergo liver transplant have a high rate of readmission. In our cohort, readmissions were unrelated to pre-existing recipient or donor factors, but were associated with a longer hospital stay after liver transplant.

REFERENCES

1. Kim WR, Smith JM, Skeans MA, Schladt DP, Schnitzler MA, Edwards EB, Harper AM, et al. OPTN/SRTR 2012 Annual Data Report: liver. Am J Transplant 2014; 14(Suppl. 1): 69-96.

2. Pereira AA, Bhattacharya R, Carithers R, Reyes J, Perkins J. Clinical factors predicting readmission after orthotopic liver transplantation. Liver Transpl 2012; 18: 1037-45.

3. Berman K, Tandra S, Forssell K, Vuppalanchi R, Burton JR, Jr., Nguyen J, Mullis D, et al. Incidence and predictors of 30- day readmission among patients hospitalized for advanced liver disease. Clin Gastroenterol Hepatol 2011; 9: 254-9.

4. Ganesh S, Rogal SS, Yadav D, Humar A, Behari J. Risk factors for frequent readmissions and barriers to transplantation in patients with cirrhosis. PLoS One 2013; 8: e55140.

5. Volk ML, Tocco RS, Bazick J, Rakoski MO, Lok AS. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol 2012; 107: 247-52.

6. Desai AP, Satoskar R, Appannagari A, Reddy KG, Te HS, Reau N, Meltzer DO, et al. Co-Management Between Hospitalist and Hepatologist Improves the Quality of Care of Inpatients With Chronic Liver Disease. J Clin Gastroenterol 2013.

7. Morando F, Maresio G, Piano S, Fasolato S, Cavallin M, Romano A, Rosi S, et al. How to improve care in outpatients with cirrhosis and ascites: a new model of care coordination by consultant hepatologists. J Hepatol 2013; 59: 257-64.

8. Shankar N, Marotta P, Wall W, Albasheer M, Hernandez-Alejandro R, Chandok N. Defining readmission risk factors for liver transplantation recipients. Gastroenterol Hepatol (NY) 2011; 7: 585-90.

9. Taner CB, Willingham DL, Bulatao IG, Shine TS, Peiris P, Torp KD, Canabal J, et al. Is a mandatory intensive care unit stay needed after liver transplantation? Feasibility of fast-tracking to the surgical ward after liver transplantation. Liver Transpl 2012; 18: 361-9.

10. Axon RN, Williams MV. Hospital readmission as an accountability measure. JAMA 2011; 305: 504-5.

11. Axelrod DA, Koffron AJ, Baker T, Al-Saden P, Dixler I, McNatt G, Sumner S, et al. The economic impact of MELD on liver transplant centers. Am J Transplant 2005; 5: 2297-301.

12. Washburn WK, Pollock BH, Nichols L, Speeg KV, Halff G. Impact of recipient MELD score on resource utilization. Am J Transplant 2006; 6: 2449-54.

13. Abecassis MM. Financial outcomes in transplantation—a provider’s perspective. Am J Transplant 2006; 6: 1257-63.

14. Abecassis M. Making dollars and sense out of liver transplantation. Liver Transpl 2009; 15: 1159-61.

15. Buchanan P, Dzebisashvili N, Lentine KL, Axelrod DA, Schnitzler MA, Salvalaggio PR. Liver transplantation cost in the model for end-stage liver disease era: looking beyond the transplant admission. Liver Transpl 2009; 15: 1270-7.

16. Englesbe MJ, Patel SP, He K, Lynch RJ, Schaubel DE, Harbaugh C, Holcombe SA, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010; 211: 271-8.